NCT00033345View on ClinicalTrials.gov

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

July 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

Indole-3-carbinol

400 mg pill taken daily

DRUG

Indole-3-carbinol

800 mg pill taken daily

OTHER

Placebo

Placebo pill taken daily during run-in period

Trial Locations (1)

66160-7320

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Kansas Medical Center

OTHER

NCT00033345 - Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer | Biotech Hunter | Biotech Hunter